BioLineRx Ltd. (BLRX)
NASDAQ: BLRX
· Real-Time Price · USD
3.75
-0.02 (-0.53%)
At close: Aug 15, 2025, 3:59 PM
3.83
2.13%
Pre-market: Aug 18, 2025, 04:02 AM EDT
BioLineRx Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | 11.53 | -53.62 | -73.52 | 923.76 | -895.34 | -81.3 | -70.35 | -52.92 | -44.85 | -53.12 | -66.72 | -82.02 | -165.37 | -209.48 | -227.23 | -183.21 | -102.11 |
PEG Ratio | -0.04 | 1.19 | 0.06 | -5.54 | 9.39 | 3.25 | 4.88 | -0.91 | -0.21 | 0.96 | 5.23 | -0.89 | 8.96 | 10.60 | 11.04 | 4.17 | 1.66 |
PS Ratio | 926.96 | 58.18 | 346.37 | 331.61 | 363.62 | 940.65 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 11.33 | 50.78 | 201.31 | 127.92 | 190.86 | 341.46 | 343.31 | 186.46 | 55.78 | 23.95 | 32.91 | 43.17 | 51.43 | 52.97 | 73.28 | 67.86 | 64.40 |
P/FCF Ratio | -91.23 | -79.44 | -174.26 | -157.48 | -176.27 | 907.93 | -454.17 | -400.37 | -267.88 | -206 | -209.83 | -385.56 | -581.93 | -648.04 | -1.04K | -732.3 | -666.29 |
P/OCF Ratio | -91.23 | -79.39 | -174.26 | -157.86 | -176.67 | 904.65 | -455.41 | -405.46 | -272.19 | -214.27 | -210.46 | -388.26 | -583.8 | -655.34 | -1.04K | -734.34 | -668.32 |
OCF/S Ratio | -10.16 | -0.73 | -1.99 | -2.1 | -2.06 | 1.04 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.66 | 1.12 | 3.48 | 2.24 | 0.87 | 0.88 | 1.01 | 0.64 | 0.33 | 0.24 | 0.19 | 0.05 | 0.06 | 0.07 | 0.08 | 0.08 | 0.11 |
Quick Ratio | 2.04 | 1.56 | 1.37 | 1.49 | 1.05 | 1.06 | 1.86 | 2.79 | 3.68 | 4.85 | 7.12 | 4.58 | 5.60 | 5.91 | 6.09 | 6.76 | 5.81 |
Current Ratio | 2.27 | 1.76 | 1.52 | 1.61 | 1.14 | 1.10 | 1.96 | 2.79 | 3.68 | 4.87 | 7.12 | 4.58 | 5.60 | 5.91 | 6.09 | 6.76 | 5.81 |
Asset Turnover | 0.01 | 0.30 | 0.09 | 0.08 | 0.13 | 0.08 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -5.69 | -1 | -3.32 | -2.77 | -5.19 | 19.92 | -14.76 | -7.42 | -9.55 | -6.33 | -26.51 | -20.06 | -32.68 | -32.34 | -23.82 | -26.91 | -18.22 |
Return on Equity | 0.25 | -0.24 | -0.68 | 0.03 | -0.05 | -1.05 | -1.22 | -0.88 | -0.31 | -0.11 | -0.12 | -0.13 | -0.08 | -0.06 | -0.08 | -0.09 | -0.16 |
Return on Assets | 0.12 | -0.08 | -0.11 | 0.01 | -0.01 | -0.22 | -0.3 | -0.31 | -0.18 | -0.08 | -0.08 | -0.11 | -0.07 | -0.05 | -0.07 | -0.07 | -0.12 |
Return on Invested Capital | -0.07 | -0.16 | -0.14 | -0.13 | -0.2 | -0.75 | -0.3 | -0.2 | -0.15 | -0.12 | -0.1 | -0.13 | -0.09 | -0.09 | -0.08 | -0.08 | -0.07 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.87 | 0.48 | 0.83 | 0.83 | 0.79 | 0.23 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | 20.11 | -0.27 | -1.18 | 0.09 | -0.1 | -2.89 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | 20.11 | -0.27 | -1.18 | 0.09 | -0.1 | -2.89 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -9.38 | -0.38 | -1.09 | -1.07 | -0.7 | -3.87 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | 22.40 | 0.26 | -0.68 | 0.56 | 0.16 | -2.94 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |